An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.
about
Current and future alternative therapies for beta-thalassemia majorCustomizing the genome as therapy for the β-hemoglobinopathiesThe therapeutic potential of genome editing for β-thalassemiaGenome-editing Technologies for Gene and Cell TherapyTowards a new era in medicine: therapeutic genome editingEnabling functional genomics with genome engineeringGenomic approaches to identifying targets for treating β hemoglobinopathiesFetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathiesGenome-scale neurogenetics: methodology and meaningQuantifying on- and off-target genome editingSickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patientsAnemia: progress in molecular mechanisms and therapiesCtip1 Regulates the Balance between Specification of Distinct Projection Neuron Subtypes in Deep Cortical Layers.Transcriptional Dynamics at Brain Enhancers: from Functional Specialization to NeurodegenerationThe selection and function of cell type-specific enhancersβ-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies2015 Clinical trials update in sickle cell anemiaTherapeutic genome editing: prospects and challengesErythro-megakaryocytic transcription factors associated with hereditary anemiaFunctional Characterization of the Osteoarthritis Susceptibility Mapping to CHST11-A Bioinformatics and Molecular StudyBCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesisThe European Hematology Association Roadmap for European Hematology Research: a consensus documentGenome-wide Association Study of Platelet Count Identifies Ancestry-Specific Loci in Hispanic/Latino AmericansFinding partners to play the music of regulationHemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.Laying a solid foundation for Manhattan--'setting the functional basis for the post-GWAS era'.SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon.Erythropoietin signaling regulates heme biosynthesis.An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference.Predicting the impact of non-coding variants on DNA methylation.Short DNA sequence patterns accurately identify broadly active human enhancersCharacterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells.Reactivation of developmentally silenced globin genes by forced chromatin looping.Characterization of transcription factor networks involved in umbilical cord blood CD34+ stem cells-derived erythropoiesis.Identifying causal variants at loci with multiple signals of associationGenome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin.Models of human core transcriptional regulatory circuitries.Association Between PIP4K2A Polymorphisms and Acute Lymphoblastic Leukemia Susceptibility.
P2860
Q26750906-504F2FE3-851A-4880-8E41-D55A788FC796Q26751061-172C8522-A944-497E-A0DF-FD08DC1681A5Q26766232-31403660-18B1-471F-94CC-0CD70119459FQ26769662-27905F6D-EBF4-4D78-A6EB-B9E403B2C8D4Q26773287-0E88D951-008E-4B1F-800B-A1E849F6E378Q26782747-C5D7E398-65AA-44EB-82B5-DAC187A58535Q26799214-BB01AD51-2111-4EA9-9A50-9C1E9E0E9EE7Q26822810-BBCBB7CE-EB28-49ED-8586-B1A66748977BQ26859474-4520300F-7DBB-414F-8FA1-1630B00EA864Q27015049-0BF5C5D9-B712-4FC7-B201-EBA0CEC9C9EFQ27016104-A692E73E-4AFB-446E-A137-3FA21C12969DQ27023172-B3B00834-2790-4B40-88C4-23A10C7B011BQ27319539-C3F081B0-88B0-4E0B-89B1-AFDD17A4FBB8Q28067751-5B880647-7DC4-45E2-A806-4256092D4B58Q28081960-4E996F15-34CF-4E6E-BBB2-AEB6C78BC3D4Q28086960-02CF2641-2163-43D0-9C86-2266F32FC968Q28086979-558EFF71-34D0-471F-8F21-7F860E9C5692Q28087380-5B1BC2E9-46DA-48D9-B3AC-EE1BF80E6952Q28236415-87205907-7119-4CC6-AF80-DA9855694693Q28596544-1BF67C9E-DC92-4295-9360-0B386522DE03Q28607483-BBDF3CCE-4391-49BD-897D-57B01496138BQ28830861-FC57462A-D406-4955-A306-581BEA419982Q30277682-77F60A21-BA7C-4196-ACB8-92133350F722Q30386324-25B687B5-845C-49BC-9ADF-CA886E59E7D2Q33361527-38EAD634-3C3F-4A81-A179-31B3E69A03A3Q33631309-02520772-6F27-490F-85EA-32C0C92DB2B2Q33667950-1E58E6B9-87A3-493A-A47B-CFAE4795E6ABQ33817885-6147F67B-EADA-41E2-B689-E099442921BCQ33850615-B717CE36-324F-4E21-9083-0FA15541F5C9Q33878882-4DD45EB2-5D49-4448-9C01-A4CFA8BB30D5Q33909150-F80000DD-39B5-405C-8413-658C30A9D754Q33985245-78EAD774-DBCD-40A1-BE91-4CE1F836E136Q34052021-835C15B6-F879-4E83-9A24-A363133E0164Q34166173-14CD7328-8D75-4987-A7EB-FC513D9F6A6BQ34336624-28FA4ECA-4E06-4779-B394-A91475F40669Q34456358-0DD5345C-C246-4C02-A802-F9F084C6ACDEQ34464896-1590C12C-BE88-415A-A6FD-7B3B90658130Q34476277-407EF052-37D9-4C86-8C12-D33797D81636Q34512262-0E31CFDE-7251-4576-925B-CE5336AF07D5Q34525231-2C42148E-6EE5-4205-B981-98608C6613B2
P2860
An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
An erythroid enhancer of BCL11 ...... rmines fetal hemoglobin level.
@en
An erythroid enhancer of BCL11 ...... rmines fetal hemoglobin level.
@nl
type
label
An erythroid enhancer of BCL11 ...... rmines fetal hemoglobin level.
@en
An erythroid enhancer of BCL11 ...... rmines fetal hemoglobin level.
@nl
prefLabel
An erythroid enhancer of BCL11 ...... rmines fetal hemoglobin level.
@en
An erythroid enhancer of BCL11 ...... rmines fetal hemoglobin level.
@nl
P2093
P2860
P50
P356
P1433
P1476
An erythroid enhancer of BCL11 ...... ermines fetal hemoglobin level
@en
P2093
Carrie Lin
Daniel E Bauer
Elenoe C Smith
Guillaume Lettre
Guo-Cheng Yuan
John A Stamatoyannopoulos
Matthew H Porteus
Peter J Sabo
Richard A Voit
P2860
P304
P356
10.1126/SCIENCE.1242088
P407
P577
2013-10-01T00:00:00Z